Accession Number: | 0001209191-22-041053 |
Date: | 2022-07-05 |
Issuer: | FATE THERAPEUTICS INC (FATE) |
Original Submission Date: |
PLAVSIC MARK
C/O FATE THERAPEUTICS, INC.
12278 SCRIPPS SUMMIT DRIVE
SAN DIEGO, CA 92131
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2022-07-05 | S | 3,719 | d | $24.61 | 127,123 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 9,500 shares of common stock underlying restricted stock units granted to the reporting person on june 14, 2021. this sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. |
f2 | represents the weighted average sale price of the shares sold from $24.34 to $24.82 per share. the reporting person will provide, upon request by the commission staff, the issuer or a security holder of he issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2. |